Literature DB >> 25125631

Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma.

Yohei Mano1, Shinichi Aishima2, Yuichiro Kubo2, Yuki Tanaka2, Takashi Motomura3, Takeo Toshima3, Ken Shirabe3, Shingo Baba4, Yoshihiko Maehara3, Yoshinao Oda5.   

Abstract

OBJECTIVES: This study investigated the association between several biological markers and fluorine-18 fluorodeoxyglucose (FDG) uptake in patients with hepatocellular carcinoma.
METHODS: Forty-two patients with hepatocellular carcinoma who underwent FDG positron emission tomography were included in the study. Tumor sections were immunohistochemically stained for phosphorylated signal transducer and activator of transcription 3 (pSTAT3), hypoxia-inducible factor 1α (HIF1α), glucose transporter 1 (GLUT1), GLUT2, GLUT3, and GLUT4.
RESULTS: The high standardized uptake value (SUV) group showed larger tumor size, more frequent vascular invasion, and poorer differentiation compared with the low SUV group. The high SUV group also showed significantly higher immunohistochemical expression of pSTAT3, HIF1α, and GLUT1. The GLUT1 high-expression group showed higher α-fetoprotein (a tumor marker) and poorer differentiation than did the GLUT1 low-expression group.
CONCLUSIONS: Our study indicates that FDG uptake is associated with the expression of pSTAT3, HIF1α, and GLUT1 in hepatocellular carcinoma. The expression of these proteins shows a correlation with poor differentiation and vascular invasion. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  FDG positron emission tomography; GLUT1; HIF1α; Hepatocellular carcinoma; STAT3

Mesh:

Substances:

Year:  2014        PMID: 25125631     DOI: 10.1309/AJCPG8AFJ5NRKLLM

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  18F-fluorodeoxyglucose PET/CT as an independent predictor for patients with hepatocellular carcinoma combined with major portal vein tumor thrombus.

Authors:  Xu-Guang Hu; Xue-Yin Shen; Jin-Niang Nan; In-Gyu Kim; Joon-Kee Yoon; Sung-Yeon Hong; Mi-Na Kim; Bong-Wan Kim; Hee-Jung Wang
Journal:  Ann Surg Treat Res       Date:  2020-06-29       Impact factor: 1.859

2.  Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth.

Authors:  Andrew G Cox; Allison Tsomides; Dean Yimlamai; Katie L Hwang; Joel Miesfeld; Giorgio G Galli; Brendan H Fowl; Michael Fort; Kimberly Y Ma; Mark R Sullivan; Aaron M Hosios; Erin Snay; Min Yuan; Kristin K Brown; Evan C Lien; Sagar Chhangawala; Matthew L Steinhauser; John M Asara; Yariv Houvras; Brian Link; Matthew G Vander Heiden; Fernando D Camargo; Wolfram Goessling
Journal:  EMBO J       Date:  2018-10-22       Impact factor: 11.598

3.  Usefulness of [18F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma.

Authors:  Liang Zhao; Yanzhen Zhuang; Kaili Fu; Peiqiong Chen; Yuhuan Wang; Jianfang Zhuo; Xiyi Liao; Haojun Chen; Qin Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-03       Impact factor: 9.236

4.  Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.

Authors:  Surbhi Chouhan; Snahlata Singh; Dipti Athavale; Pranay Ramteke; Vimal Pandey; Jomon Joseph; Rajashekar Mohan; Praveen Kumar Shetty; Manoj Kumar Bhat
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

5.  Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells.

Authors:  Jie Liu; Hao Ren; Bin Liu; Qingyu Zhang; Mingyi Li; Runzhi Zhu
Journal:  Oncol Lett       Date:  2016-10-19       Impact factor: 2.967

6.  Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT.

Authors:  Chengfang Shangguan; Guifang Gan; Jieying Zhang; Jinliang Wu; Ying Miao; Miao Zhang; Biao Li; Jun Mi
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

7.  The assessment of correlation and prognosis among 18F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients.

Authors:  Hayato Kaida; Koichi Azuma; Akihiko Kawahara; Eiji Sadashima; Satoshi Hattori; Shinzo Takamori; Jun Akiba; Kiminori Fujimoto; Axel Rominger; Takamichi Murakami; Kazunari Ishii; Masatoshi Ishibashi
Journal:  Oncotarget       Date:  2018-08-10

8.  RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.

Authors:  Wen Zhang; Duo Tong; Fei Liu; Dawei Li; Jiajia Li; Xi Cheng; Ziliang Wang
Journal:  Oncotarget       Date:  2016-02-02

9.  Immunohistochemical and Biochemical Expression Patterns of TTF-1, RAGE, GLUT-1 and SOX2 in HCV-Associated Hepatocellular Carcinomas

Authors:  Tarek Aboushousha; Samah Mamdouh; Hussam Hamdy; Noha Helal; Fatma Khorshed; Gehan Safwat; Mohamed Seleem
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

10.  Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues.

Authors:  Israa T Ismail; Oliver Fiehn; Ashraf Elfert; Marwa Helal; Ibrahim Salama; Hala El-Said
Journal:  Cancers (Basel)       Date:  2020-02-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.